Rani Therapeutics Holdings, Inc.
RANI
$1.39
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.21% | 1.66% | 2.93% | -26.05% | 26.25% |
| Total Depreciation and Amortization | -13.90% | -5.88% | 1.21% | 17.18% | 18.81% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 125.47% | 76.39% | 63.93% | 141.12% | 71.49% |
| Change in Net Operating Assets | 60.37% | 1,401.23% | -97.59% | 62.14% | 24.07% |
| Cash from Operations | 39.80% | 35.81% | 13.33% | 30.64% | 41.20% |
| Capital Expenditure | 100.00% | 60.64% | -183.33% | 81.44% | 73.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -13.13% | 77.27% | -81.01% | -95.11% |
| Cash from Investing | -100.00% | -12.44% | 77.08% | -81.01% | -95.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -70.88% | 2,291.52% | -65.29% | 9,668.75% | 12,829.49% |
| Repurchase of Common Stock | 50.00% | 66.67% | -- | -- | 51.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.08% | -- | -- | -- | -- |
| Cash from Financing | -113.10% | 33.33% | -3,183.47% | 5,753.13% | 15,622.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,462.03% | 104.44% | 526.75% | -157.74% | 90.81% |